SPVN-20

N/A

Report date: 2025/07/16 17:21:30

Base Information

Drug NameSPVN-20
Drug Alias NameSPVN-20
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionG Protein-Coupled Inwardly-Rectifying Potassium Channels gene transference
TargetsG Protein-Coupled Inwardly-Rectifying Potassium Channels
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGamut Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesSparingVision Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A